Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Investors Itic Stock A Good Buy In 2026 Price At 221.65 Up 1.32 20260406 Is Forte Biosciences Fbrx Stock Near Resistance Price At 25.77 Up 0.74 20260406 Is Mfs High Muni Cxe Stock Breaking Out Price At 3.69 Down 0.14 20260406 Should I Hold Youxin Yaas Stock Now Price At 0.95 Down 1.64 20260406 Is Soundhound Ai Soun Stock Consolidating Price At 6.83 Up 0.66 20260406 Is Forte Biosciences Fbrx Stock Near Resistance Price At 25.77 Up 0.74 20260406 Is Collplant Clgn Stock Leading The Market Price At 0.34 Down 10.99 20260413 Is Procter Pg Stock Consolidating Price At 142.81 Down 0.21 20260406 Is Southstate Ssb Stock Good For Long Term Ssb Q4 2025 Earnings Southstate Bank Corporation Beats Eps Est By 0.17 20260406 1 Can Bionexus Lab Bglc Stock Go Higher Price At 2.23 Up 0.98 20260406 How Does Macroeconomics Affect Regional Management Rm Stock Price At 37.39 Up 2.83 20260413 Is Ssr Mining Ssrm Stock Moving Higher Price At 31.68 Up 0.30 20260406 Is Cn Energy Cney Stock In A Selling Zone Price At 0.37 Down 7.44 20260406 Market Moves Tech leads broad gains while consumer sector lags Is Toll Brothers TOL stock a safe investment Bullish Sentiment 20260418 Rogers Corporation ROG Stock Worth Entering Technical Weakness 20260415 Columbia COLM Stock Sell Side Rating Climbs 20260418 General Mills GIS LongTerm View Q1 2026 Below Expectations John HEQ Stock Swing Trade Setup Trend Weakens 20260415 When to Sell Talon TLNCU Stock Ticks Higher 20260415 Martin MMLP Stock Research Q4 2025 Profit Disappoints Generac Holdlings GNRC Full Analysis Q4 2025 Profit Disappoints SCYX SCYNEXIS Inc reports 873 percent Q4 2025 EPS beat shares climb 571 percent in todays trading Lowes Companies Inc LOW Valuation Assessment Amid AI Supply Chain Rollout and Pro Segment Expansion Amgen Inc AMGN Partners with Zai Lab to Advance DLL3Targeted ADC Candidate ZL1310 Following Promising AACR Clinical Data APLM Apollomics highlights oncology pipeline progress and upcoming clinical trial milestones in its latest quarterly earnings report